肠道微生物对酸盐寡糖的同化以及在减轻肠道炎症的潜在作用
Xiao-Qing Ma1, Bing Wang1, Wei Wei2
1Qingdao C1 Refinery Engineering Research Center, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao, China.
Applied and environmental microbiology
|April 2, 2024
概括
肠道微生物通过特定的酸盐利用位点 (AUL) 使用酸盐寡糖化物 (AOS). 这种新陈代谢影响短链脂肪酸和氨基酸通路,可能改善肠道健康并保护大肠炎.
科学领域:
- 微生物学 微生物学
- 肠道微生物组研究研究
- 饮食纤维的新陈代谢
背景情况:
- 食纤维,特别是来自海藻的酸盐,已得到认可的生物活动.
- 酸寡糖 (AOS) 是生物活性成分,但它们的肠道代谢和健康影响需要进一步阐明.
- 了解肠道中的酸盐同化对于利用其健康益处至关重要.
研究的目的:
- 研究人类肠道微生物对酸盐同化机制.
- 识别和描述涉及加工不和酸盐寡糖化物 (uAOS) 的酸盐利用位置 (AUL).
- 探索UAOS发酵的代谢后果及其对宿主健康的影响.
主要方法:
- 使用生化和转录组数据,重建酸盐利用位点 (AUL) 的工作模型,用于*Bacteroides clarus*.
- 对单糖发酵通路的分析,特别是恩特纳-杜多罗夫通路.
- 在体内研究涉及uAOS在急性结肠炎的小鼠模型中食.
主要成果:
- 证明了在人类肠道微生物群中存在UAOS特异性的AUL.
- 阐明了UAOS同化代谢途径,导致单糖的产生.
- 表明UAOS发酵调节短链脂肪酸和氨基酸代谢.
- 观察到uAOS养对小鼠的硫酸德克斯诱导的急性结肠炎提供了保护.
结论:
- 肠道微生物具有特定的酸盐利用位点 (AUL) 来处理不和酸盐寡糖化物 (uAOS).
- 肠道微生物对uaOS的新陈代谢影响宿主能量代谢和氨基酸概况.
- uAOS新陈代谢在维持肠道健康方面发挥作用,并可能为诸如结肠炎等炎症性疾病提供治疗潜力.
相关概念视频
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
210
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
210
Drugs for Treatment of Ulcerative Colitis in IBD
138
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
138
Drugs for Treatment of Diarrhea-Predominant IBS
166
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
166
Drugs Affecting GI Tract Motility: Other Laxatives
209
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
209
Drugs for Treatment of Constipation-Predominant IBS
162
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
162
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
196
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
196


